Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Recenti Progressi in Medicina|August 1, 2015
[18F-FDG PET/CT in ocular and orbital abnormalities not only neopastic: comparison with traditional imaging]Corinna Altini, Artor Niccoli Asabella, Cristina Ferrari, et al.Nuclear Medicine Review. Central & Eastern Europe|September 27, 2013
18F-FDGPET/CT: diabetes and hyperglycaemiaArtor Niccoli-Asabella, Francesca Iuele Iuele, Nunzio Merenda, et al.Clinical Imaging|August 13, 2013
18F-FDG PET/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up)Artor Niccoli-Asabella, Antonio Notaristefano, Domenico Rubini, et al.Diagnostics (Basel, Switzerland)|September 28, 2021
Immune Checkpoint Inhibitors in Advanced NSCLC: [<sup>18</sup>F]FDG PET/CT as a Troubleshooter in Treatment ResponseCristina Ferrari, Giulia Santo, Nunzio Merenda, et al.Recenti Progressi in Medicina|April 11, 2019
[Role of 18F-FDG PET/CT in comparison with CECT for whole-body assessment of patients with esophageal cancer.]Corinna Altini, Artor Niccoli Asabella, Valentina Lavelli, et al.Recenti Progressi in Medicina|October 26, 2012
[Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125]Giuseppe Rubini, Corinna Altini, Antonio Notaristefano, et al.Nuclear Medicine Communications|November 1, 2012
A retrospective study comparing contrast-enhanced computed tomography with 18F-FDG-PET/CT in the early follow-up of patients with retroperitoneal sarcomasArtor Niccoli-Asabella, Corinna Altini, Antonio Notaristefano, et al.Medicine|February 3, 2017
Pediatric Hodgkin Lymphoma: Predictive value of interim 18F-FDG PET/CT in therapy response assessmentCristina Ferrari, Artor Niccoli Asabella, Nunzio Merenda, et al.Journal of Clinical Medicine|July 19, 2020
Usefulness of <sup>18</sup>F-FDG PET/CT in Patients with Cardiac Implantable Electronic Device Suspected of Late InfectionGiuseppe Rubini, Cristina Ferrari, Domenico Carretta, et al.Recenti Progressi in Medicina|September 18, 2013
[18F-FDG PET/CT in staging and restaging cholangiocarcinoma]Antonio Notaristefano, Artor Niccoli Asabella, Amato Antonio Stabile Ianora, et al.Pageof 2